Roy Buchanan Analyst Performance

Analyst at JMP Securities

Roy Buchanan is a stock analyst at JMP Securities, covering 19 publicly traded companies across a range of sectors. Over the past year, Roy Buchanan has issued 24 stock ratings, including buy and hold recommendations. While full access to Roy Buchanan's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Roy Buchanan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 51 Last 10 Years
Buy Recommendations: 91.84% 45 Buy Ratings
Companies Covered: 19 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	91.8%	45 ratings
Hold	8.2%	3 ratings
Sell	0.0%	0 ratings

Out of 49 total stock ratings issued by Roy Buchanan at JMP Securities, the majority (91.8%) have been Buy recommendations, followed by 8.2% Hold.

Best & Worst Calls

Best Call
0000.0%
CLVS
Apr 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
NVUS
Apr 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	89.5% of companies on NASDAQ	17 companies
NYSE	5.3% of companies on NYSE	1 company
NYSEMKT	5.3% of companies on NYSEMKT	1 company

Roy Buchanan, an analyst at JMP Securities, currently covers 19 companies listed on NASDAQ, NYSE and NYSEMKT, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	94.7%
	Finance 1 company	5.3%

Roy Buchanan of JMP Securities specializes in stock coverage within the Medical sector, with additional focus on Finance companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 6 companies	31.6%
MED - DRUGS 5 companies	26.3%
PHARMACEUTICAL PREPARATIONS 4 companies	21.1%
BIOTECHNOLOGY 2 companies	10.5%
FIN - INVEST MGMT 1 company	5.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	5.3%

Time Frame

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
DVAX Dynavax Technologies	8/22/2025	Reiterated Rating	$10.95	$32.00	Market Outperform
ENTA Enanta Pharmaceuticals	8/12/2025	Boost Price Target	$6.49	$25.00	Market Outperform
CDTX Cidara Therapeutics	8/8/2025	Boost Price Target	$61.60	$66.00	Market Outperform
DVAX Dynavax Technologies	8/8/2025	Boost Price Target	$10.15	$32.00	Market Outperform
CDTX Cidara Therapeutics	6/30/2025	Reiterated Rating	$49.45	$59.00	Market Outperform
PYPD PolyPid	6/17/2025	Lower Price Target	$3.53	$14.00	Market Outperform
ENTA Enanta Pharmaceuticals	6/3/2025	Boost Price Target	$7.09	$24.00	Market Outperform
CDTX Cidara Therapeutics	6/2/2025	Reiterated Rating	$21.56	$47.00	Market Outperform
CVAC CureVac	5/28/2025	Reiterated Rating	$4.38	$10.00	Market Outperform
CDTX Cidara Therapeutics	5/27/2025	Reiterated Rating	$24.28	$47.00	Market Outperform
CDTX Cidara Therapeutics	5/9/2025	Boost Price Target	$18.90	$47.00	Market Outperform
DVAX Dynavax Technologies	5/7/2025	Lower Price Target	$9.65	$31.00	Market Outperform
ANTX (ANTX)	5/5/2025	Lower Price Target	$1.23	$2.00	Market Outperform
CDTX Cidara Therapeutics	4/29/2025	Reiterated Rating	$20.98	$46.00	Market Outperform
CDTX Cidara Therapeutics	3/12/2025	Set Price Target	$22.98	$46.00
CVAC CureVac	2/14/2025	Reiterated Rating	$3.63	$16.00	Market Outperform
TPG TPG	2/13/2025	Reiterated Rating	$60.16		Market Perform
ESPR Esperion Therapeutics	2/11/2025	Reiterated Rating	$1.74	$4.00	Market Outperform
ENTA Enanta Pharmaceuticals	2/11/2025	Reiterated Rating	$5.64	$21.00	Market Outperform
ANTX (ANTX)	2/3/2025	Reiterated Rating	$1.14	$5.00	Market Outperform
IRWD Ironwood Pharmaceuticals	1/30/2025	Lower Price Target	$3.72	$14.00	Market Outperform
ESPR Esperion Therapeutics	1/23/2025	Reiterated Rating	$2.16	$7.00	Market Outperform
ABVX Abivax	1/10/2025	Reiterated Rating	$6.63	$33.00	Market Outperform
INO Inovio Pharmaceuticals	1/10/2025	Reiterated Rating	$2.01	$18.00	Market Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.